General Information of Drug (ID: DMC4IUQ)

Drug Name
5-(N,N-hexamethylene)-amiloride Drug Info
Synonyms
5-(N,N-Hexamethylene)amiloride; Hexamethyleneamiloride; 1428-95-1; Hexamethylene amiloride; HMA-5; HMA; C12H18ClN7O; 3-Amino-6-chloro-5-(1-homopiperidyl)-N-(diaminomethylene)pyrazinecarboxamide; N,N-HEXAMETHYLENEAMILORIDE; CHEBI:76400; 3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide; 3-Amino-N-(aminoiminomethyl)-6-chloro-5-(hexahydro-1H-azepin-1-yl)pyrazinecarboxamide; Pyrazinecarboxamide, 3-amino-N-(aminoiminomethyl)-6-chloro-5-(hexahydro-1H-azepin-1-yl)-; 5-HMA; Spectrum_001596
Cross-matching ID
PubChem CID
1794
ChEBI ID
CHEMBL501701
CAS Number
CAS 1428-95-1
TTD Drug ID
D02YIW
VARIDT Drug ID
DR00899

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Signaling pathways regulating pluripotency of stem cell... 1.91 3.76e-2 110/143 (76.92%) FGFR4;FZD2;CTNNB1;...
Axon guidance 1.85 3.14e-2 151/182 (82.97%) SEMA6A;EFNA1;PAK1;...
Basal cell carcinoma 1.83 3.35e-2 41/63 (65.08%) BMP2;CDKN1A;FZD2;...
Primary immunodeficiency 1.83 2.51e-2 33/38 (86.84%) BLNK;RFX5;CD79A;...
Renin-angiotensin system 1.77 4.77e-2 20/23 (86.96%) CPA3;ACE2;AGTR1;...
Complement and coagulation cascades -1.64 4.69e-2 76/85 (89.41%) SERPINB2;PLAU;PROS1;...
Pertussis -1.66 4.95e-2 64/76 (84.21%) C5;GNAI2;MAPK1;...
Staphylococcus aureus infection -1.72 3.45e-2 72/95 (75.79%) MBL2;C3AR1;C5;...
beta-Alanine metabolism -1.72 3.63e-2 25/30 (83.33%) ACOX1;CNDP2;MLYCD;...
Ferroptosis -1.77 2.86e-2 36/41 (87.8%) SLC11A2;CYBB;SAT1;...
Legionellosis -1.85 1.34e-2 51/57 (89.47%) TLR5;CASP7;RELA;...
Phenylalanine metabolism -1.86 9.33e-3 14/17 (82.35%) HPD;DDC;MAOA;...
Cysteine and methionine metabolism -2.10 0.00e+0 43/50 (86%) PHGDH;GCLC;SDS;...
Arginine and proline metabolism -2.15 0.00e+0 39/50 (78%) PRODH2;CKM;NOS3;...
Glycine, serine and threonine metabolism -2.17 0.00e+0 31/40 (77.5%) ALAS2;SARDH;SRR;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H